HepaPredict AB
559057-7044ActiveSpecialized CRO using 3D liver spheroids for drug toxicity prediction.
Oversikt
- 1–4
- Ansatte
- 1–2.5mill SEK
- Omsetning
- 2016
- Grunnlagt
Nøkkelbeslutningstakere
Volker Lauschke
Co-founder and CEO
Magnus Ingelman-Sundberg
Co-founder and Chairman of the Board
Bo Qwarnström
Member of the Board
Sabine U. Vorrink
Chief Operating Officer (COO)
Beskrivelse
HepaPredict AB is a specialized Contract Research Organization (CRO) founded in 2016 as a spin-off from Karolinska Institutet. The company focuses intensely on drug metabolism, toxicity assessment, and drug development services specifically related to liver diseases. Their primary offering revolves...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Teknisk provning och analys
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE559057704401
Beslutningstakere
4 kontakter i FunnelfeedrVolker Lauschke
Co-founder and CEO
Magnus Ingelman-Sundberg
Co-founder and Chairman of the Board
Bo Qwarnström
Member of the Board
Sabine U. Vorrink
Chief Operating Officer (COO)
Lignende bedrifter
19 lignende bedrifter i FunnelfeedrLegado Bioresearch AB
2 ansatteExpert CRO providing specialized in vivo research and consulting services.
Lucero AB
7 ansatteDeveloping thaw-and-dose spheroids for faster preclinical drug discovery.
Cell2Bio AB
2 ansattePlatform enabling high-performance 3D cell spheroid growth for research.
True Dose AB
1–4 ansatteEmpowering precision dosing via innovative at-home blood sampling technology.
Medetect AB
5 ansatteCutting-edge histology and image analysis solutions for drug discovery.
Spørsmål om HepaPredict AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo